Studies in adolescent animals suggest that some components of the developing serotonergic system respond to SSRI treatment in a similar fashion to the adult system. For example, chronic (over 22 days) ...

Neuroscientists recently identified molecular mechanisms in the brain that may explain why the active ingredient (fluoxetine) in selective serotonin reuptake inhibitors (SSRIs) sold under brand names ...

Our histological analysis reveals that serotonin type 3 receptor (5HT3R) and insulin-like growth factor 1 (IGF1) are expressed in the same neurons in the subgranular zone of the hippocampal dentate ...

With the advent of new technology, comes a better understanding of the brain and the hope for novel treatments and medications with improved specificity and therapeutic efficacy. The most widely used ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. Existing drugs used to treat depression and other mood disorders might ...

Cannabinoids promote neurogenesis in embryonic and adult rats, and produce anxiolytic- and antidepressant-like effects, according to a new report in the current issue of The Journal of Clinical ...

Please provide your email address to receive an email when new articles are posted on . Antidepressants, particularly SSRIs like escitalopram, were tied to a faster cognitive decline. Higher dispensed ...